Current perspectives on the immunopathogenesis of sarcoidosis

Respir Med. 2020 Nov:173:106161. doi: 10.1016/j.rmed.2020.106161. Epub 2020 Sep 22.

Abstract

Sarcoidosis is an inflammatory systemic disease that commonly affects the lungs or lymph nodes but can manifest in other organs. Herein, we review the latest evidence establishing how innate and adaptive immune responses contribute to the pathogenesis and clinical course of sarcoidosis. We discuss the possible role of microbial organisms as etiologic agents in sarcoidosis and the evidence supporting sarcoidosis as an autoimmune disease. We also discuss how animal and in vitro human models have advanced our understanding of the immunopathogenesis of sarcoidosis. Finally, we discuss therapeutics for sarcoidosis and the effects on the immune system.

Keywords: Adaptive immune responses; Innate immune responses; Sarcoidosis.

Publication types

  • Review

MeSH terms

  • Adaptive Immunity*
  • Animals
  • Autoimmunity*
  • B-Lymphocytes / immunology
  • Biological Factors / pharmacology
  • Biological Factors / therapeutic use
  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • Disease Progression
  • Glucocorticoids / pharmacology
  • Glucocorticoids / therapeutic use
  • Humans
  • Immune System / immunology*
  • Immunity, Innate*
  • Molecular Targeted Therapy
  • Sarcoidosis / drug therapy
  • Sarcoidosis / etiology*
  • Sarcoidosis / immunology*
  • Th17 Cells

Substances

  • Biological Factors
  • Glucocorticoids